India

INR overview

PairLatest rateToday's change1 year change
INRGBP0.0107
GBP
0.00 / 0.00%0.00003 / 0.29%
Today
0.0105Dec 13 20190.012Jul 30 2019
INREUR0.0127
EUR
0.000001 / 0.01%0.0003 / 2.67%
Today
0.0121Feb 04 20190.0132Aug 01 2019
INRUSD0.014
USD
0.00 / 0.00%-0.0001 / -0.78%
Today
0.0138Sep 03 20190.0146Jul 11 2019
INRJPY1.52
JPY
0.00 / 0.00%-0.0214 / -1.38%
Today
1.46Aug 26 20191.63Apr 03 2019
INRAUD0.0207
AUD
0.00 / 0.00%0.001 / 5.29%
Today
0.0192Feb 05 20190.0213Aug 02 2019
INRCAD0.0184
CAD
-0.00001 / -0.07%-0.0002 / -1.04%
Today
0.018Jan 06 20200.0195Jun 03 2019
INRCNY0.0971
CNY
0.00 / 0.00%0.0019 / 2.00%
Today
0.0936Feb 27 20190.1012Sep 27 2019
INRCHF13.57
CHF
0.00 / 0.00%-0.4457 / -3.18%
Today
13.44Jan 08 202014.75May 03 2019

Equity fund country flows

This chart shows the cumulative weekly equity in country flows into or out of India in USD. EPFR Global provides global coverage of foreign investor flows, tracking over 15,000 funds domiciled around the world.
As of Jan 15 2020.

Market movers

Constituents of the NX 100 Index - NSE with the highest percent gain over one day.
ListingLastChangeVolume
Dr.Reddy's Laboratories LtdDRREDDY:NSI3,188.75
INR
+157.35
+5.19%
4.14m
GlaxoSmithKline Pharmaceuticals LtdGLAXO:NSI1,675.60
INR
+36.30
+2.21%
116.15k
Aurobindo Pharma LtdAUROPHARMA:NSI511.00
INR
+9.90
+1.98%
4.84m
REC LtdRECLTD:NSI144.10
INR
+2.65
+1.87%
5.32m
Mahindra and Mahindra LtdM&M:NSI578.30
INR
+10.55
+1.86%
3.65m
Cummins India LtdCUMMINSIND:NSI605.25
INR
+10.10
+1.70%
1.92m
Apollo Hospitals Enterprise LtdAPOLLOHOSP:NSI1,696.05
INR
+27.35
+1.64%
791.55k
Lupin LtdLUPIN:NSI751.90
INR
+11.75
+1.59%
1.49m
Container Corporation of India LtdCONCOR:NSI570.20
INR
+8.85
+1.58%
1.28m
Glenmark Pharmaceuticals LtdGLENMARK:NSI356.15
INR
+5.40
+1.54%
2.69m
Data delayed at least 15 minutes, as of Jan 27 2020 10:28 GMT.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.